APA (7th ed.) Citation

D, A., K, W., MY, T., JE, T., GG, O., M, B., . . . H, A. (2024). Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 37(10), 100557. https://doi.org/10.1016/j.modpat.2024.100557

Chicago Style (17th ed.) Citation

D, Akbulut, et al. "Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications." Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc 37, no. 10 (2024): 100557. https://doi.org/10.1016/j.modpat.2024.100557.

MLA (9th ed.) Citation

D, Akbulut, et al. "Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications." Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc, vol. 37, no. 10, 2024, p. 100557, https://doi.org/10.1016/j.modpat.2024.100557.